De novo donor‐specific anti‐HLA antibodies mediated rejection in liver‐transplant patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1432-2277|28|12|1371-1382

ISSN： 0934-0874

Source： TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol.28, Iss.12, 2015-12, pp. : 1371-1382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful living donor liver retransplantation for graft failure within 7 days due to acute de novo donor‐specific anti‐human leukocyte antigen antibody‐mediated rejection

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E360-E366

John Wiley & Sons Inc

Access to resources Recommend Favorite

Donor‐specific anti‐HLA antibodies in pediatric renal transplant recipients with creeping creatinine: Prevalence, histological correlations, and impact on patient and graft survival

By  

PEDIATRIC TRANSPLANTATION, Vol. 1397-3142, Iss. 7, 2015-11 ,pp. : 684-690

John Wiley & Sons Inc

Access to resources Recommend Favorite

Donor‐specific anti‐HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development and Impact of De Novo Anti‐HLA Antibodies in Pediatric Heart Transplant Recipients

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 8, 2015-08 ,pp. : 2215-2222

John Wiley & Sons Inc

Access to resources Recommend Favorite

A suspected case of plasma cell‐rich acute renal transplant rejection associated with de novo donor‐specific antibody

By  

NEPHROLOGY, Vol. 20, Iss. S2, 2015-07 ,pp. : 66-69

John Wiley & Sons Inc

Access to resources Recommend Favorite